Home › Funds › Venrock Adviser, LLC › ANL

Venrock Adviser, LLC position in ANL

ADLAI NORTYE GROUP LTD · Health Care

Venrock Adviser, LLC reported holding 3,212,731 shares of ANL (ADLAI NORTYE GROUP LTD) in its Q2 2026 13F filing — a position valued at US$36.9M, representing 1.12% of its reported portfolio and ranking #19 among its reported holdings. Venrock Adviser, LLC has disclosed ANL holdings in 2 of the last 2 reported quarters, going back to Q1 2026.

Latest position (Q2 2026)3.21M sh
Reported value held$36.95M
Portfolio Weight1.12%
First reportedQ1 2026
Last changeHold
Updated2026-10-24

Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR

How Venrock Adviser, LLC's ANL position evolved

Venrock Adviser, LLC first disclosed a stake in ANL in Q1 2026 at 3,212,731 shares (US$22.2M). The position peaked in Q2 2026 at 3,212,731 shares, worth US$36.9M. Across 2 filings, Venrock Adviser, LLC held the position steady without any share-count change. The most recent filing (Q2 2026) shows 3,212,731 shares valued at US$36.9M.

Quarter by quarter

QuarterSharesValueChange
Q1 2026 3.21M $22.23M New
Q2 2026 3.21M $36.95M Hold

Dots on the line are colored by change type; missing quarters mean no position was reported.

About ANL and 13F data

ANL (ADLAI NORTYE GROUP LTD) is a Health Care company. 41 other funds we track also report a position in ANL — the largest reported positions include Cormorant Asset Management, LP (US$45.7M), MPM BioImpact LLC (US$22.3M), Casdin Capital (US$14.4M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding ANL

All ANL fund holders →

FAQ

How long has Venrock Adviser, LLC held ANL?

Venrock Adviser, LLC has disclosed ANL holdings in 2 of the last 2 reported quarters, going back to Q1 2026.

What is Venrock Adviser, LLC's current position in ANL?

As of Q2 2026, Venrock Adviser, LLC holds 3.21M shares of ANL (ADLAI NORTYE GROUP LTD), valued at $36.95M, representing 1.12% of its reported portfolio and ranking #19.

Has Venrock Adviser, LLC been buying or selling ANL?

In the latest 13F filing (Q2 2026), Venrock Adviser, LLC held unchanged its position in ANL. The position peaked in Q2 2026 at 3.21M shares.

Which other funds hold ANL?

Other major institutional holders of ANL include Cormorant Asset Management, LP, MPM BioImpact LLC, Casdin Capital, among 41 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.